Who founded Simergent?

Simergent was founded by Steve J. Lindo, Rick Pendergraft in 2016.

Who are Simergent's investors?

Simergent's investors include Angel Physicians Fund, Pathway Bioventures, Plains Ventures.

How much funding has Simergent raised?

Simergent has disclosed $8.8M raised across 1 round.

Where is Simergent headquartered?

Simergent is headquartered in Chicago, US.

Simergent

Chicago, US · Founded 2016 · Delaware LLC · 6 employees on LinkedIn · 3 known investors

Find your way into Simergent

303 people in our graph share verified history with the Simergent team — schools, employers, funds. One of them is your warm intro.

Tianlin Wangunlockedknows Steve J. Lindo · together at University of Oklahoma

×4knows the team · via Southern Methodist University

×7knows the team · via University of Oklahoma

Simergent develops medical device systems for regulated healthcare markets, with expertise in peritoneal dialysis and infusion pump technologies. The company is led by engineers with FDA clearance experience and clinical advisory from nephrologists.

Biotech Healthtech Medical Devices

Founders & leadership

Simergent was founded in 2016 by Steve J. Lindo and Rick Pendergraft.

Steve J. Lindo inCo-founder & CEOSteve J. Lindo is co-founder and CEO of Simergent, a medical device company developing peritoneal dialysis and infusion pump systems. He has prior experience in medical device development, healthcare investment, and management consulting.

Rick PendergraftinCo-founder & Chief Technology Officer

Dr. James SloandChief Medical Officer

Michael RohlederManager

Investors · 3

Angel Physicians Fund

Pathway BioventuresChicago

Plains VenturesOklahoma City · $250K – $1M

Reported raises · per SEC filings

Form D private placements

$8.8M disclosed across 1 round · 2024

▶$8.8MraisedMar 2026 · 57 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Michael RohlederExecutive Officer, Director
Rick PendergraftExecutive Officer, Director
Steve J LindoExecutive Officer, Director

Offering amount: $9.9M
Amount sold: $8.8M
Minimum investment: $18.4K
First sale: Mar 2024
Incorporated: Limited Liability Company, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2021	$1.7M
National Institutes of Health (NIH)National Institutes of Health	Phase I	2017	$218.5K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Simergent do?: Simergent develops medical device systems for regulated healthcare markets, with expertise in peritoneal dialysis and infusion pump technologies. The company is led by engineers with FDA clearance experience and clinical advisory from nephrologists.
Who founded Simergent?: Simergent was founded by Steve J. Lindo, Rick Pendergraft in 2016.
Who are Simergent's investors?: Simergent's investors include Angel Physicians Fund, Pathway Bioventures, Plains Ventures.
How much funding has Simergent raised?: Simergent has disclosed $8.8M raised across 1 round.
Where is Simergent headquartered?: Simergent is headquartered in Chicago, US.